IDNAvsJDOC
iShares Genomics Immunology and Healthcare ETF against JPMorgan Healthcare Leaders ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IDNA | JDOC | |
|---|---|---|
| Expense ratio | 0.47% | 0.65% |
| Assets | $299M | $9048.54T |
| Net flow, 1 month | +$20M | — |
| Net flow, 1 year | +$75M | −$25K |
| Return, YTD | +59.0% | +2.8% |
| Return, 1 year | +71.1% | +10.2% |
| Avg daily volume | 185K | 248 |
| Holdings | 63 | 67 |
| Listed | Jun 11, 2019 | Oct 31, 2023 |
| Options market | Yes | No |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS